Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Nelson

Showing results (1231-1240 of 1,373) with videos related to

Pageof 138
Sort By:
Transplantation|January 12, 1999
Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatchingC F Bryan, K A Baier, P W Nelson, et al.
Virus Evolution|June 27, 2018
Selective constraint and adaptive potential of West Nile virus within and among naturally infected avian hosts and mosquito vectorsChase W Nelson, Samuel D Sibley, Sergios-Orestis Kolokotronis, et al.
Molecular and Cellular Endocrinology|November 28, 2016
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificityAdam W Nelson, Arnoud J Groen, Jodi L Miller, et al.
Clinical Transplantation|March 21, 2002
IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotypeC F Bryan, J Martinez, N Muruve, et al.
Kidney International|May 21, 2015
Sequencing rare and common APOL1 coding variants to determine kidney disease riskSophie Limou, George W Nelson, Laurence Lecordier, et al.
International Journal of Radiation Oncology, Biology, Physics|September 23, 2008
Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinomaJohn W Nelson, A Paiman Ghafoori, Christopher G Willett, et al.
Molecular Pharmacology|February 20, 2009
Regulator of G protein signaling protein suppression of Galphao protein-mediated alpha2A adrenergic receptor inhibition of mouse hippocampal CA3 epileptiform activityBrianna L Goldenstein, Brian W Nelson, Ke Xu, et al.
Nature Chemistry|October 25, 2013
A clamp-like biohybrid catalyst for DNA oxidationStijn F M van Dongen, Joost Clerx, Kasper Nørgaard, et al.
The Journal of Molecular Diagnostics : JMD|December 20, 2025
Development and Clinical Validation of OncCNV: A Pipeline for Comprehensive Genome-Wide Analysis of Oncogene Amplifications, Homozygous Deletions, and Biallelic Inactivation of Tumor Suppressor Genes Using the TruSight Oncology 500 KitStephanie A Smoley, Gopinath Sivasankaran, Mallika Gandham, et al.
Molecular Pharmacology|March 8, 2007
Alpha2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 regionChris W D Jurgens, Hana M Hammad, Jessica A Lichter, et al.
Pageof 138

Showing results (1231-1240 of 1,373) with videos related to

Sort By:
Pageof 138
Transplantation|January 12, 1999
Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatchingC F Bryan, K A Baier, P W Nelson, et al.
Virus Evolution|June 27, 2018
Selective constraint and adaptive potential of West Nile virus within and among naturally infected avian hosts and mosquito vectorsChase W Nelson, Samuel D Sibley, Sergios-Orestis Kolokotronis, et al.
Molecular and Cellular Endocrinology|November 28, 2016
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificityAdam W Nelson, Arnoud J Groen, Jodi L Miller, et al.
Clinical Transplantation|March 21, 2002
IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotypeC F Bryan, J Martinez, N Muruve, et al.
Kidney International|May 21, 2015
Sequencing rare and common APOL1 coding variants to determine kidney disease riskSophie Limou, George W Nelson, Laurence Lecordier, et al.
International Journal of Radiation Oncology, Biology, Physics|September 23, 2008
Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinomaJohn W Nelson, A Paiman Ghafoori, Christopher G Willett, et al.
Molecular Pharmacology|February 20, 2009
Regulator of G protein signaling protein suppression of Galphao protein-mediated alpha2A adrenergic receptor inhibition of mouse hippocampal CA3 epileptiform activityBrianna L Goldenstein, Brian W Nelson, Ke Xu, et al.
Nature Chemistry|October 25, 2013
A clamp-like biohybrid catalyst for DNA oxidationStijn F M van Dongen, Joost Clerx, Kasper Nørgaard, et al.
The Journal of Molecular Diagnostics : JMD|December 20, 2025
Development and Clinical Validation of OncCNV: A Pipeline for Comprehensive Genome-Wide Analysis of Oncogene Amplifications, Homozygous Deletions, and Biallelic Inactivation of Tumor Suppressor Genes Using the TruSight Oncology 500 KitStephanie A Smoley, Gopinath Sivasankaran, Mallika Gandham, et al.
Molecular Pharmacology|March 8, 2007
Alpha2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 regionChris W D Jurgens, Hana M Hammad, Jessica A Lichter, et al.
Pageof 138